GIANT CELL ARTERITIS (GCA)
Clinical trials for GIANT CELL ARTERITIS (GCA) explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS (GCA) trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS (GCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
Disease control Not yet recruitingThis study tests whether people with giant cell arteritis (GCA) can safely take steroids for only 8 weeks instead of the usual 26 weeks when also using the drug tocilizumab. About 178 participants will be randomly assigned to one of two treatment lengths. The goal is to see if th…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Could a blood vessel drug help tame giant cell arteritis?
Disease control Not yet recruitingThis study tests whether adding bosentan to standard steroid treatment helps people with giant cell arteritis (GCA) stay relapse-free longer and use less steroids. About 40 adults with GCA will receive either bosentan plus steroids or steroids alone for 3 months, then be followed…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC
-
New scanner aims to sharpen diagnosis of blood vessel disease
Diagnosis Not yet recruitingThis study will test a new type of PET/CT scanner (called long-axial field-of-view) to see if it can provide clearer images of inflammation in the blood vessels of people with large vessel vasculitis. Researchers will compare scans from 18 participants (12 with vasculitis and 6 h…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: NA • Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 22, 2026 11:59 UTC
-
Real-World data sought on upadacitinib for rare artery disease
Knowledge-focused Not yet recruitingThis study observes 80 adults with giant cell arteritis (GCA) affecting large arteries who are taking upadacitinib as part of their routine care. Researchers will collect data from medical records to see how many achieve remission at 24 weeks and track relapses over 2 years. No e…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Could arthritis and arteritis be connected? new study investigates
Knowledge-focused Not yet recruitingThis study aims to see if there is a connection between two types of inflammatory conditions: one affecting the spine and joints (spondylarthritis) and another affecting blood vessels (giant cell arteritis) or muscles (polymyalgia rheumatica). Researchers will compare 10 adults w…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Hôpital NOVO • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New scan could reveal hidden immune cells in blood vessel disease
Knowledge-focused Not yet recruitingThis study will use a special scan to look for B cells (a type of immune cell) in the blood vessels of 30 people with giant cell arteritis, a serious disease that can cause blindness or stroke. Current treatments rely on steroids, which have harsh side effects. If the scan works,…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:08 UTC